Concern Over Cancer Waiting Times in England
It appears that nearly all hospital trusts in England are not meeting the crucial NHS waiting time expectations for cancer treatment, according to a recent analysis by the BBC.
Out of 121 trusts, only three are managing to provide timely care within the necessary 62-day period. Experts fear that these delays could indeed be jeopardizing patients’ lives.
The government acknowledges that the waiting times are excessive but suggests that investments in the NHS are underway to enhance performance.
Research highlights the significance of prompt treatment, noting that every additional four-week wait can decrease survival rates by around 10%.
Dr. Timothy Hanna, a prominent cancer expert, expressed concern over these findings, describing them as “worrying.” He remarked, “It’s not a few outliers. It’s the norm for trusts in England to not hit these waiting time targets, and they are set for a reason—timely treatment can improve survival rates.”
One patient, Paul, grappling with stage three colon cancer, reflects on his frustrating experience. Diagnosed in January 2024, he underwent a biopsy only to face a significant delay until January of this year before receiving any updates. After finally having surgery in February, he voiced a common sentiment, saying, “The waiting was horrendous and now I think that if I had been treated properly and not had to wait so long it wouldn’t have progressed to stage three.” He’s scheduled for additional surgery next year.
Challenges Faced by Hospitals
Hospitals cite that the demand for testing and treatment is exceeding their capabilities. The issues are compounded by instances of equipment failures, lost GP referral letters, and staffing shortages leading to last-minute appointment cancellations.
A thorough review by BBC Verify covered the performance of every major cancer service in England from September 2024 to August 2025.
Essential targets are in place for the cancer journey: trusts should aim to diagnose or rule out cancer in 75% of urgent cases within 28 days, begin treatment for 96% of patients within 31 days, and complete the entire process within 62 days for 85% of cases. Alarmingly, nearly 25% of trusts have missed all three targets in the past year, with some large regional hubs overwhelmed with inherited waits from smaller facilities.
‘We Can’t Deliver the Care We Aim For’
The Royal Free NHS Trust in London, which ranks poorly in 62-day wait times at 109 out of 121, is experiencing its own challenges. Although it functions as a specialized kidney cancer center and has acquired new equipment, administrative issues can lead to critical surgeries being canceled. For instance, just the day before a scheduled filming by the BBC, a theatre remained unoccupied as a patient had not received their confirmation letter.
Moreover, one of the trust’s two radiotherapy machines is over a decade old, prompting the need for updates due to performance declines.
Claire Hartill, the head of radiotherapy at the Royal Free, stated, “We can’t deliver the service we want to, and it can cause delays to patient treatment,” emphasizing the necessity for more modern equipment. A funding request to the government for a new machine was unfortunately rejected earlier this year.
How the Best Performers Are Achieving Target Goals
Interestingly, only three cancer services—Calderdale and Huddersfield, East and North Hertfordshire, and Bolton NHS trusts—have met the 62-day targets over the past year. Their success seems to stem from efficient communication, top-of-the-line equipment, and solid teamwork.
In a related personal narrative, Paul, recently diagnosed with prostate cancer, shares that he received a quick diagnosis and was promptly consulted about his treatment options at the Lister Hospital in Stevenage. Upon deciding on a surgical option, the scheduling was efficient enough for him to agree to a date that even fell on a Saturday—an all-too-rare occurrence in the system.
At the same time, innovative approaches are being explored in chemotherapy treatment; a new project is teaching patients to administer certain types of chemotherapy at home. Josephine Hoskins, who requires injections every three weeks and commutes between London and Devon, describes this method as transformational for her situation. This shift immediately frees up resources for those needing more complex care.
‘Determined to Make Improvements’
The government has expressed a commitment to tackle waiting times. An updated cancer strategy is anticipated early next year, following cancer’s designation as a ‘core priority’ in the recent NHS 10-year plan.
A spokesperson for the Department of Health stated, “Cancer care is a priority as we turn around more than a decade of neglect of our NHS. We’re focused on ensuring timely diagnoses and treatments, building more community diagnostic centers, and allocating £70 million for new radiotherapy machines to improve patient access to necessary tests and scans.”
However, health analyst Sarah Scobie from the Nuffield Trust cautions that navigating the issues brought to light by the BBC’s findings will be exceedingly difficult with the current financial constraints.
Data Overview
The BBC’s analysis utilized official cancer waiting time statistics from NHS England for the span of September 2024 to August 2025. While the NHS updates this data monthly, the assessment focused on overall annual performance against the three national benchmarks, evaluating trusts based on their 62-day waiting time measures spanning from urgent referrals to treatment initiation.
